NCT00915980

Brief Summary

In many studies, gastric bypass surgery led to total remission of type 2 diabetes (T2DM) as early as 1 - 2 days after surgery before any real weight loss has occurred. This suggests that the remission of the T2DM is due to the direct effect of the operation, more than the secondary effect of the weight loss. The reasons for the major effect on the glucose metabolism after gastric bypass surgery are still unaccounted for. The aim of this project will be to unveil some of the mechanisms that explain the effect of gastric bypass surgery on the glucose metabolism. Further more to find a better way of testing patients that have just undergone gastric bypass surgery. It is not possible to test patients who have just undergone gastric bypass surgery with normal oral glucose tolerance test (OGTT) and a normal meal, because patients can only take in fluid and a normal OGTT will often lead to dumping. Instead we will try to modify these tests - OGTT with lower glucose level and meal-testing with a protein drink. The hypothesis of the study is that the investigators can see changes in different hormones and adipokines before and after surgery, even with modified OGTT and meal testing. The project will consist of clinical trials on patients without T2DM that will undergo gastric bypass surgery. The studies will take place before and within the first week after surgery. The investigators will measure different hormones and adipokines after OGTT and a meal with a protein drink. The investigators expect to see significant changes in some of the analyses after the operation in patients undergoing gastric bypass.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2008

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2009

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 5, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 8, 2009

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2010

Completed
Last Updated

July 8, 2011

Status Verified

July 1, 2011

Enrollment Period

1.3 years

First QC Date

June 5, 2009

Last Update Submit

July 6, 2011

Conditions

Keywords

Meal-testreduced OGTTgastric bypass surgery and glucose metabolismGlucose metabolism before and after gastric bypassDifferent OGTTNew meal- test

Study Arms (1)

Patients without diabetes undergoing gastric bypass

Procedure: gastric bypass surgery and testing

Interventions

The patients will be tested with OGTT and meal testing before and after undergoing gastric bypass surgery.

Patients without diabetes undergoing gastric bypass

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Obese with BMI \> 40 undergoing gastric bypass surgery or obese with BMI \> 35 with complications of their obesity in form of high blood pressure or other related complications undergoing gastric bypass surgery.

You may qualify if:

  • Obese with BMI\> 40 undergoing gastric bypass surgery OR
  • Obese with BMI \> 35 with complications of their obesity in form of high blood pressure or other related complications undergoing gastric bypass surgery
  • Age between 20-60 years

You may not qualify if:

  • Age \> 60
  • Diabetes
  • Psychiatric illness
  • Mentally challenged
  • Addiction
  • Serious cardiac or lung diseases
  • Diseases in the abdomen
  • Other serious illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hvidovre hospital

Hvidovre, 2650, Denmark

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

plasma and serum sampels for analysis of primarily intestinal hormones

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 5, 2009

First Posted

June 8, 2009

Study Start

January 1, 2008

Primary Completion

May 1, 2009

Study Completion

October 1, 2010

Last Updated

July 8, 2011

Record last verified: 2011-07

Locations